Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-14

FDA Approved: LITHIUM — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approves Advagen Pharma Ltd's generic lithium carbonate product under an Original Application (ANDA 218036).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium (Lithium carbonate)

Snippet

ORIG AP for LITHIUM (LITHIUM)